The Lancet
Randomized Controlled Trial
Community Care for HIV, HTN, Diabetes Matches Clinic-Based Model
A trial in Tanzania and Uganda found non-inferior HIV suppression and comparable cardiometabolic control in a community-based model.
The Lancet
Randomized Controlled Trial
Pimicotinib Yields 54% Response in Tenosynovial Giant Cell Tumors
The selective inhibitor pimicotinib demonstrates high efficacy for unresectable joint tumors while avoiding severe hepatotoxicity.
The Lancet
Randomized Controlled Trial
Baxdrostat Reduces 24-Hour Blood Pressure in Resistant Hypertension
A phase 3 trial shows the selective aldosterone synthase inhibitor baxdrostat reduces systolic blood pressure by 14 mm Hg versus placebo.